Form 8-K - Current report:
SEC Accession No. 0001937653-25-000047
Filing Date
2025-08-07
Accepted
2025-08-07 16:09:02
Documents
14
Period of Report
2025-08-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K zyme-20250807.htm   iXBRL 8-K 38381
2 EX-99.1 ex991q22025_earningsxrelea.htm EX-99.1 106813
6 zw_logoa.jpg GRAPHIC 13528
  Complete submission text file 0001937653-25-000047.txt   295920

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT zyme-20250807.xsd EX-101.SCH 1788
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT zyme-20250807_lab.xml EX-101.LAB 21629
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT zyme-20250807_pre.xml EX-101.PRE 12512
16 EXTRACTED XBRL INSTANCE DOCUMENT zyme-20250807_htm.xml XML 2815
Mailing Address 108 PATRIOT DRIVE, SUITE A MIDDLETOWN DE 19709
Business Address 108 PATRIOT DRIVE, SUITE A MIDDLETOWN DE 19709 302-274-8744
Zymeworks Inc. (Filer) CIK: 0001937653 (see all company filings)

EIN.: 883099146 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)